© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 0.79% of CNSP shares are held by financial institutions. PRIME CAPITAL INVESTMENT ADVISORS, LLC is the top corporate investor, holding 10.73K shares valued at $2.00K. A 0.03% stake in CNS Pharmaceuticals, Inc. is owned by the company. GRADIENT INVESTMENTS LLC owns 200 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the CNSP insiders holding of 1.04% of the stake in company, CLIMACO JOHN M, Chief Executive Officer, holds the largest shares of 215.68K. PRIEBE WALDEMAR, 10 percent owner, is the second largest CNSP insider with ownership of 156.81K shares. DOWNS CHRISTOPHER, Chief Financial Officer, stands third with possession of 103.44K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CNSP shares is 12, representing 0.79% of the company's common stock.
CITIGROUP INC, in the last quarter, reduced its stake in CNSP by -100% restricting it's holding to 0 shares of worth nearly -. MILLENNIUM MANAGEMENT LLC also lessened -100% of the CNSP shares from its portfolio, reducing its holding to 0 shares of worth -. CITADEL ADVISORS LLC also shunned CNSP shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, BANK OF AMERICA CORP /DE/ increased its stake in CNSP by 100% in the last quarter. The institutional holder raised its holding to 177 shares having worth more than -. VANGUARD GROUP INC also added 6.06% more shares of CNSP to its portfolio, raising its holding to 453.62 thousand shares of worth $81.00K. TWO SIGMA SECURITIES, LLC also increased its CNSP shares holding by 100% which brought its holding to 90.49 thousand shares worth $16.00K.
The insider with the most stakes in CNSP is Climaco John M , Chief Executive Officer at the company. Additionally, CNSP stock is highly held by 10 percent owner Priebe Waldemar and Chief Financial Officer Downs Christopher among others.
Company executives, directors, and other insiders own 1.04% percent of CNS Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CNSP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include PRIEBE WALDEMAR.
There have been 0 transaction(s) during the past 6-months in which CNS Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares
Around 0 CNS Pharmaceuticals, Inc. shares are held by insiders, which represents about 1.04% of CNSP stock.
CNSP Chief Executive Officer, Climaco John M holds the largest portfolio of the company's shares. CNSP shares owned by Climaco total nearly 215.68 thousand.
PRIME CAPITAL INVESTMENT ADVISORS, LLC is the largest institutional owner in CNSP which holds 10.73 thousand shares worth $2.00K or 0.03% of the total CNSP shares outstanding followed by GRADIENT INVESTMENTS LLC with ownership of 200 shares representing 0% of the CNSP ownership. BANK OF AMERICA CORP /DE/ is the third largest stakeholder with 177 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CNSP is concerned, it is a stock which is not optionable.
Number of CNSP shares short is 1.14M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 57.49M shares of CNSP are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CNSP has 31.43M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CNSP is 0.04.